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Abstract
Purpose We aimed to investigate the association of body
mass index (BMI), waist circumference (WC), and waist-
to-height ratio (WHtR) with cardiometabolic risk.
Methods In this cross-sectional study, 21,038 men and
15,604 women who participated in a health check-up were
included.
Results In both men and women, the area under the curve
(AUC) of WHtR was significantly greater than that of BMI
or WC in the prediction of diabetes, hypertension, high
total cholesterol, high triglycerides, and low HDL-choles-
terol (P \ 0.05 for all). The AUC for WHtR in the pre-
diction of metabolic syndrome (MS) was also highest in
the women (P \ 0.05). After adjustment for potential
confounders, the odds ratios and 95% confidence intervals
for MS for each standard deviation increase in BMI,
WHtR, and WC were 1.47 (1.46–1.49), 1.32 (1.31–1.33),
and 1.19 (1.18–1.19), respectively. Finally, patients of
either sex with a normal BMI or WC level, but with an
elevated WHtR, had higher levels of various cardiometa-
bolic risk factors in comparison with their normal BMI or
WC, but low WHtR, counterparts (P \ 0.05 for all).
Conclusion Among Taiwanese adults, a WHtR greater
than 0.5 is a simple, yet effective indicator of centralized
obesity and associated cardiometabolic risk, even among
individuals deemed ‘healthy’ according to BMI and WC.
Keywords Waist-to-height ratio  Waist circumference 
Obesity  Diabetes  Body mass index  Asian
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Introduction
Current estimates from the International Obesity Task
Force suggest that at least 1.1 billion people across the
globe are overweight and 312 million of them are obese
[1]. It is now well established that obesity, as most com-
monly defined according to body mass index (BMI), sub-
stantially increases the risk of type-2 diabetes [2],
hypertension [2], cardiovascular disease [3], and all-cause
mortality [4]. However, it has become accepted that the
location of excess adiposity is a strong determinant of
cardiometabolic risk [5]. Specifically, the central deposi-
tion of excess weight has been proven to be a stronger
predictor of risk of morbidity [6–10] and mortality [11] in
comparison with overall obesity, as defined by BMI alone.
Although waist circumference (WC) is often advocated
as a simple and accurate anthropometric marker of central
obesity and associated cardiometabolic risk [12], and its
use has been adopted into clinical screening guidelines
[13], the measure is not without limitations. First, WC
cutoff points cannot be used universally across gender or
race [14]. Indeed, the optimal WC cutoffs for denoting
cardiometabolic risk may even differ between Asians from
different countries [15, 16]. The application of WC to
assess cardiometabolic risk also assumes, albeit errone-
ously, that risk stratification is not influenced by patient
height. For example, it has recently been shown that the
risk of metabolic syndrome within a given WC strata is
significantly higher among shorter individuals [17].
The waist-to-height ratio (WHtR) is an alternative
anthropometric index of central obesity that circumvents
the limitations of WC [18]. First, due to the inclusion of
height into the index, any potential confounding of car-
diometabolic risk by height is avoided. Second, studies
have found similar WHtR cutoffs for increased cardio-
metabolic risk among Caucasian [19] and Asian [20]
populations as well as men and women [21]. In fact, a
WHtR cutoff value of 0.5 has been proposed as an indicator
of cardiometabolic risk for both Japanese [22], Korean
[23], and British [19] men and women. Finally, WHtR has
also been shown to denote cardiometabolic risk among
individuals who are not obese according to other anthro-
pometric indices [23–25].
Despite apparently low levels of obesity [26] relative to
those reported in North America [27], the rates of diabetes
[28] and metabolic syndrome [29] among Taiwanese are
alarmingly high. Thus, there remains a need to elucidate
proper anthropometric criteria to delineate Taiwanese
individuals at the highest cardiometabolic risk. The aim of
the current study was threefold: (1) to investigate the
association of BMI, WC, and WHtR with diabetes mellitus,
hypertension, dyslipidemia, and metabolic syndrome in a
large sample of Taiwanese individuals; (2) to determine the
cutoff points of BMI, WC, and WHtR predictive of car-
diometabolic risk factors; and (3) to quantify cardiometa-
bolic risk among those who have elevated WHtR, but
normal BMI or WC.
Subjects and methods
Subjects
Data on 38,406 adult (C18 years) Taiwanese subjects who
had health check-ups in 2010 were retrospectively col-
lected from the health centers located in four separate
branches of Chang-Gung Memorial Hospital, including the
Keelung and Linkou branches of northern Taiwan and the
Chiayi and Kaohsiung branches of southern Taiwan. Sub-
jects with incomplete data, as well as those who were
pregnant or had a chronic disease that may affect the
metabolic status or body composition (e.g., thyroid or
hypothalamic disease, chronic hepatitis, and cirrhosis),
were excluded from analysis (n = 1,764). The sample used
for the current analysis consisted of 21,038 men and 15,604
women.
Collection of data
All data collection was conducted during a single visit by
full-time nurses at the health examination center who had
received uniform training and adhered to the standard
operating procedure (SOP). Nurses at each participating
health center administered questionnaires regarding life-
style (including smoking and drinking), medical history
(including past illness history and medication history), and
physiological conditions (including pregnancy and fasting
time) to all subjects during their health check-up. The
nurses verified the completion of each questionnaire prior
to collection. During the same visit, blood pressure, height,
weight, and waist circumstance were measured, and fasting
blood samples were taken. All subject information was
coded electronically and entered into a central subject
record database. In order to ensure quality control, a
monitor was employed by the investigational institution to
review the data collection process through sampling with
an SOP check list.
Anthropometric measurements
The height meter was calibrated daily using a one-meter
standard bar from the Bureau of Standards, Metrology, and
Inspection, Taiwan. Height was measured while subjects
stood erect, barefoot, with feet together, looking forward.
The weight scale was calibrated daily using two 20-kg
standard weights. Weight was measured by an automatic
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scale with subjects wearing light shirt and shorts or a skirt.
BMI was then calculated as weight in kg divided by height
in meters squared (kg/m2). Normal BMI level was classi-
fied as 18.5–23.9 kg/m2, as per the guidelines set forth by
the Taiwan Department of Health. WC was measured at the
mid-level between the iliac crest and the lower border of
the twelfth rib while the subject stood with feet 25–30 cm
apart. A normal WC level in men and women was defined
as \90 and \80 cm, respectively.
Measurement of cardiometabolic risk factors
After a 10-min rest, blood pressure (BP) was recorded with
the subject in the seated position using an automated
sphygmomanometer placed on the subject’s right arm. BP
was measured three times, and the lowest reading was
recorded. Individuals were deemed hypertensive if they
were taking antihypertensive medications, if they self-
reported a diagnosis of hypertension, if their systolic
pressure was above 140 mm Hg, if their diastolic pressure
was above 90 mm Hg, or if a combination of these features
was recorded [30]. Subjects fasted for a minimum of 12 h
and avoided a high-fat diet and alcohol consumption for at
least 24 h prior to phlebotomy. A fasting venous blood
sample was obtained between 5:30 am and 11:00 am and
stored in a 4 C refrigerator prior to analysis in the hospital
laboratory. Clinical chemistry workup included total cho-
lesterol, HDL-C, TG, fasting plasma glucose (FPG), and
uric acid. Blood tests were carried out by the College of
American Pathologists (CAP)-accredited hospital labora-
tory in accordance with the laboratory SOP. Participants
were considered to have diabetes if they reported current
usage of antidiabetic medications, reported a previous
diagnosis of diabetes or had an FPG glucose above
126 mg/dl [31]. In terms of lipid variables, the cutoff
points were as follows: hypercholesterolemia (plasma TC
C240 mg/dl and/or use of medications to lower blood
cholesterol), hypertriglyceridemia (TG C200 mg/dl), low
HDL-C (HDL-C\40 mg/dl in men and women), and high
LDL-C (LDL-C C160 mg/dl and/or use of medications to
lower blood cholesterol) [32].
A diagnosis of metabolic syndrome was defined as a
subject presenting at least 3 of the 5 factors described by
the Third Adult Treatment Panel (ATP III) of the National
Cholesterol Education Program (NCEP) [33]. The diag-
nostic criteria were defined as follows: (1) high blood
pressure (a systolic blood pressure C130 mm Hg and/or
diastolic pressure C85 mm Hg, under treatment, or already
diagnosed with hypertension); (2) high serum triglyceride
(C150 mg/dl or under treatment); (3) decreased HDL-C
(\40 mg/dl for males and \50 mg/dl for females or under
treatment); (4) hyperglycemia (FBG C100 mg/dl, under
treatment, or previously diagnosed with diabetes mellitus);
and abdominal obesity. Waist circumference cutoffs were
modified for Asian populations [2]. A waist circumference
C90 cm for men and C80 cm for women plus the other
two risk factors or the waist circumstance within the
threshold plus the other three or more risk factors resulted
in a diagnosis of metabolic syndrome.
Statistical analyses
Comparisons between men and women were made using
independent samples t tests for continuous data and chi-
square tests for categorical data. Pearson’s correlation
coefficients were used to determine the correlation between
anthropometric indices and cardiometabolic risk factors. A
receiver operating characteristic (ROC) curve is a graphical
plot of the true-positive rate (sensitivity) versus the false-
positive rate (100-specificity) for a binary variable across a
range of thresholds. In the current study, the ROC curves
were used to demonstrate the discriminatory ability of an
anthropometric index (e.g., WC) over the entire range of
possible values in the detection of a cardiometabolic out-
come (i.e., diabetes) as quantified by the area under the
curve (AUC). The optimal cutoff point for each anthro-
pometric variable in the prediction of a given cardiomet-
abolic outcome was established based on the highest
combination of sensitivity and specificity. Odds ratios
(ORs) were calculated using multiple logistic regression
analysis and are presented with their 95% confidence
intervals (CIs). P \ 0.05 was considered to be statistically
significant. The data were analyzed using SPSS version
12.0 for Windows (SPSS, Inc, Chicago, IL, USA). Pairwise
comparison of ROC curves was made using MedCalc for
Windows, version 9.38 (MedCalc Software, Mariakerke,
Belgium).
Results
The basic characteristics and the prevalence of cardio-
metabolic risk factors of the 21,038 men and 15,604
women in the study sample are presented in Table 1. The
men and women in the sample were comparable in terms of
mean age (37.2 ± 9.4 and 37.3 ± 10.4 years, respectively,
P = 0.437), prevalence of diabetes (1.3 vs. 1.2%,
P = 0.477), and high total cholesterol (5.2 vs. 5.0%,
P = 0.467). However, there were significant differences
between the men and women in all other assessed variables
(all P \ 0.001). Specifically, men had a higher BMI
(24.8 ± 3.5 vs. 22.5 ± 4.0 kg/m2), WC (84.8 ± 9.1 vs.
73.3 ± 9.4 cm), and WHtR (0.49 ± 0.05 vs. 0.46 ± 0.06)
in comparison with women. The prevalence of hyperten-
sion (6.2% vs. 3.8%), smoking (29.6% vs. 8.8%), alcohol
consumption (37.5% vs. 11.5%), high TG (13.3% vs.
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3.8%), and low HDL-C (16.8% vs. 3.4%) was also higher
in the men than in the women, respectively.
The correlations between anthropometric indices and
cardiometabolic risk factors are shown in Table 2. In both
men and women, BMI, WC, and WHtR were all signifi-
cantly correlated with each cardiometabolic risk factor
(P \ 0.05). In comparison with BMI and WC, the WHtR
was a stronger correlate of FBG, TC, and TG in both men
and women.
The AUCs of the three anthropometric indices in the
prediction of cardiometabolic risk factors are shown in
Table 3. In both sexes, the AUC of WHtR was significantly
higher than that of BMI or WC in the prediction of diabetes
mellitus, hypertension, high TC, high TG, and low HDL-C
Table 1 Characteristics of study population
Men (n = 21,038) Women (n = 15,604) P value
Age (years)a 37.24 ± 9.39 37.33 ± 10.35 0.437
BMI (kg/m2)b 24.82 ± 3.54 22.52 ± 3.95 \0.001*
WC (cm)a 84.76 ± 9.07 73.26 ± 9.36 \0.001*
WHtRa 0.494 ± 0.053 0.462 ± 0.061 \0.001*
SBP (mm Hg)a 126.67 ± 13.87 115.91 ± 15.69 \0.001*
DBP (mm Hg)a 78.90 ± 10.14 72.22 ± 10.00 \0.001*
FBG (mg/dl)a 91.93 ± 18.48 90.27 ± 18.68 \0.001*
TC (mg/dl)a 184.18 ± 33.01 179.57 ± 33.17 \0.001*
TG (mg/dl)a 130.57 ± 103.71 86.01 ± 58.12 \0.001*
HDL-C (mg/dl)a 49.72 ± 11.16 61.29 ± 13.34 \0.001*
TC/HDL-C ratioa 3.87 ± 1.08 3.05 ± 0.82 \0.001*
Diabetes mellitus, n (%)b 278 (1.3) 193 (1.2) 0.477
Hypertension, n (%)b 1,311 (6.2) 594 (3.8) \0.001*
High TC, n (%)b 1,094 (5.2) 785 (5.0) 0.467
High TG, n (%)b 2,797 (13.3) 590 (3.8) \0.001*
Low HDL-C, n (%)b 3,530 (16.8) 532 (3.4) \0.001*
Current drinker, n (%)b 7,897 (37.5) 1,794 (11.5) \0.001*
Current smoker, n (%)b 6,230 (29.6) 1,377 (8.8) \0.001*
All numbers are means ± standard deviation unless specified
P values are from a independent two sample t tests or b chi-square tests
BMI body mass index, WC waist circumference, WHtR waist-to-height ratio, FBG fasting blood glucose, SBP systolic blood pressure, DBP
diastolic blood pressure, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol
* Indicates significant difference between men and women, P \ 0.05
Table 2 Pearson’s correlation coefficients between anthropometric indices and cardiometabolic risk factors in men and women
BMI WC WHtR
Men Women Men Women Men Women
SBP 0.367* 0.443* 0.359* 0.423* 0.363* 0.437*
DBP 0.345* 0.379* 0.333* 0.348* 0.343* 0.348*
FBG 0.159* 0.260* 0.181* 0.286* 0.205* 0.296*
TC 0.188* 0.193* 0.204* 0.201* 0.237* 0.233*
TG 0.263* 0.362* 0.275* 0.382* 0.293* 0.402*
HDL-C -0.329* -0.346* -0.330* -0.344* -0.325* -0.339*
Uric acid 0.330* 0.406* 0.306* 0.381* 0.289* 0.383*
Data are correlation coefficients
BMI body mass index, WC waist circumference, WHtR waist-to-height ratio, FBG fasting blood glucose, SBP systolic blood pressure, DBP
diastolic blood pressure, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol
* P \ 0.05
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(P \ 0.05 for all). Additionally, the AUC for the prediction
of MS was highest for WHtR in the women (AUC = 0.920),
but for WC in the men (AUC = 0.861).
Table 4 summarizes the optimal cutoff points of the
three anthropometric indices in the prediction of
cardiometabolic risk factors using ROC analysis. Among
men, the optimal BMI cutoff values for predicting diabetes
mellitus, hypertension, MS, and dyslipidemia varied from
24.5 to 25.7 kg/m2; meanwhile, the optimal WC cutoff
values varied from 83.7 to 89.4 cm, and the optimal WHtR
Table 3 AUC for various anthropometric indices and cardiometabolic risk factors in men and women
Risk factor BMI WC WHtR
Men (n = 21,038)
Diabetes mellitus 0.624 (0.592, 0.656) 0.689 (0.683, 0. 695) 0.741 (0.735, 0.747)*
Hypertension 0.593 (0.586, 0.600) 0.704 (0.698, 0.710) 0.735 (0.729, 0.741)*
Metabolic syndrome 0.839 (0.833, 0.846) 0.861 (0.855, 0.867)* 0.858 (0.852, 0.864)
High TC 0.619 (0.603, 0.635) 0.629 (0.613, 0.644) 0.652 (0.637, 0.667)*
High TG 0.705 (0.659, 0.714) 0.705 (0.696, 0.714) 0.720 (0.711, 0.729)*
Low HDL-C 0.509 (0.502, 0.512) 0.678 (0.668, 0.687) 0.680 (0.671, 0.689)*
Women (n = 15,604)
Diabetes mellitus 0.771 (0.764, 0.778) 0.827 (0.821, 0.833) 0.845 (0.840, 0.851)*
Hypertension 0.797 (0.791, 0.804) 0.814 (0.807, 0.820) 0.835 (0.829, 0.841)*
Metabolic syndrome 0.897 (0.890, 0.905) 0.915 (0.908, 0.921) 0.920 (0.914, 0.926)*
High TC 0.657 (0.638, 0.676) 0.660 (0.641, 0.680) 0.684 (0.665, 0.702)*
High TG 0.784 (0.768, 0.801) 0.798 (0.782, 0.814) 0.818 (0.803, 0.832)*
Low HDL-C 0.765 (0.746, 0.785) 0.761 (0.742, 0.780) 0.763 (0.745, 0.782)
Data are AUC (95% confidence interval)
BMI body mass index, WC waist circumference, WHtR waist-to-height ratio, FBG fasting blood glucose, SBP systolic blood pressure, DBP
diastolic blood pressure, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol
* AUC is significantly larger than the next smaller AUC; significance was calculated only for the difference between parameters with the highest
and second highest AUC, P \ 0.05
Table 4 Cutoff points for anthropometric indices predictive of cardiometabolic risk factors













Men (n = 21,038)
Diabetes mellitus 25.28 60.4 59.8 86.95 68.3 61.3 0.503 78.1 59.7
Hypertension 25.74 62.4 66.7 87.90 64.0 67.03 0.509 69.1 65.8
Metabolic syndrome 25.34 83.1 69.5 89.35 78.4 83.3 0.514 80.1 77.4
High TC 24.53 66.2 51.7 83.65 72.6 78.0 0.482 79.1 44.2
High TG 24.65 75.1 65.4 85.95 70.8 60.5 0.496 75.5 58.2
Low HDL-C 24.74 69.7 58.1 85.95 65.6 60.8 0.496 69.0 58.3
Women (n = 15,604)
Diabetes mellitus 23.91 72.0 72.4 80.40 70.5 81.5 0.497 80.3 76.3
Hypertension 23.46 77.9 69.8 76.40 80.5 71.3 0.485 81.8 72.3
Metabolic syndrome 23.95 87.4 78.5 73.45 88.0 85.5 0.497 89.2 82.7
High TC 22.59 64.2 61.3 75.70 57.2 67.6 0.470 65.4 63.5
High TG 22.76 82.2 63.4 76.95 75.9 71.6 0.484 78.6 71.5
Low HDL-C 23.10 74.8 66.2 75.70 71.6 67.7 0.467 79.5 61.5
BMI body mass index, WC waist circumference, WHtR waist-to-height ratio, FBG fasting blood glucose, SBP systolic blood pressure, DBP
diastolic blood pressure, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol
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values varied from 0.48 to 0.51. Among women, the BMI
cutoff values for predicting cardiometabolic risk varied
between 22.6 and 24.0 kg/m2, while those for WC and
WHtR varied between 73.5 and 80.4 cm, and 0.47 and
0.50, respectively.
In order to compare the relative strengths of the asso-
ciation of BMI, WC, and WHtR with MS, we calculated
the ORs (95% CI) of MS for each 1 SD increase in the
anthropometric indicators. The global goodness of fit of the
models was assessed using the Bayesian Information Cri-
terion (BIC). After adjustment for age, gender, tobacco,
and alcohol consumption, the OR (95% CI) for MS was
higher for BMI (1.473 [1.457–1.489]) than for WHtR
(1.320 [1.310–1.330]) or WC (1.188 [1.182–1.194]). The
corresponding BIC values were the lowest for WHtR and
highest for BMI (data not shown).
The normal weight subjects (n = 18,186) constituted
49.6% of the total population. Of the 8,594 normal weight
men, 233 (2.7%) had central obesity as defined by a
WHtR C 0.514. As outlined in Table 5, the centrally
obese, normal weight men were older and had greater
levels of SBP, DBP, FBG, TC, TG, TC/HDL-C ratio, and
uric acid in comparison with their normal weight and non-
centrally obese counterparts. Of the 9,592 normal weight
women, 600 (6.3%) had central obesity (WHtR C 0.497).
The centrally obese, normal weight women were older and
had greater levels of SBP, DBP, FBG, TC, TG, TC/HDL-C
ratio, and uric acid in comparison with normal weight and
non-centrally obese women.
The normal WC subjects (n = 27,469) constituted
47.7% of the total population. Of the 15,261 normal WC
men, 1,699 (11.1%) had central obesity as defined by a
WHtR C 0.514; meanwhile, of the 12,208 normal WC
women, 678 (5.6%) had central obesity (WHtR C 0.497).
Similar to the results reported among normal weight sub-
jects, the centrally obese but normal WC men and women
were older and had greater levels of SBP, DBP, FBG, TC,
TG, TC/HDL-C ratio, and uric acid in contrast to non-
centrally obese and normal WC counterparts (Table 6).
Discussion
Using a BMI cutoff of C27.0 kg/m2, estimates suggest
that the prevalence of obesity in Taiwanese men and
women is 10.5 and 13.2%, respectively [26]. In contrast,
rates of obesity (BMI C30.0 kg/m2) in the United States
are approximately three times as high (32.2 and 35.5%
in men and women, respectively) [27]. Despite the
threefold difference in obesity prevalence, rates of dia-
betes in Taiwan and United States are nearly identical
(9.2% [28] and 7.9% [2], respectively), and rates of
metabolic syndrome in Taiwan are not far behind those
in the United States (15.7% [29] and 23.7% [34],
respectively). Thus, even when applying Asian-specific
thresholds, BMI appears to be a relatively poor predictor
of cardiometabolic risk among Taiwanese adults. The
findings of this study, which include data from over
36,000 men and women, suggest that a simple measure
of centralized obesity (WHtR) may be a superior mea-
sure of cardiometabolic risk among Taiwanese. Addi-
tionally, WHtR may identify cardiometabolic risk even
among individuals deemed ‘healthy’ according to more
established indices (BMI and WC).
Table 5 Demographic and cardiometabolic risk factors in normal weight (body mass index 18.5–23.9 kg/m2) adults by WHtR
Men (n = 8,594)
Waist-to-height ratio
Women (n = 9,592)
Waist-to-height ratio
\0.514 (n = 8,361) C0.514 (n = 233) P value \0.497 (n = 8,992) C0.497 (n = 600) P value
Age (years) 35.74 ± 8.73 50.92 ± 14.49 \0.001* 35.96 ± 8.74 44.45 ± 13.83 \0.001*
SBP (mm Hg) 122.26 ± 12.17 129.89 ± 15.05 \0.001* 112.30 ± 12.98 120.11 ± 18.40 \0.001*
DBP (mm Hg) 75.84 ± 8.77 80.28 ± 10.87 \0.001* 70.27 ± 8.81 72.99 ± 10.31 \0.001*
FBG (mg/dl) 89.08 ± 14.03 99.07 ± 26.61 \0.001* 84.62 ± 12.59 92.83 ± 19.08 \0.001*
TC (mg/dl) 177.73 ± 31.09 193.92 ± 37.01 \0.001* 176.41 ± 31.15 186.73 ± 37.14 \0.001*
TG (mg/dl) 102.81 ± 74.84 149.02 ± 119.81 \0.001* 74.23 ± 40.84 105.52 ± 76.79 \0.001*
HDL-C (mg/dl) 53.24 ± 11.34 49.52 ± 10.88 \0.001* 63.64 ± 12.93 58.13 ± 12.76 \0.001*
TC/HDL-C ratio 3.47 ± 0.89 4.07 ± 1.09 \0.001* 2.85 ± 0.66 3.33 ± 0.87 \0.001*
Uric acid 6.25 ± 1.15 6.53 ± 1.32 0.002* 4.51 ± 0.90 4.91 ± 1.16 \0.001*
Values are means ± SD, and P values are from independent two sample t tests
FBG fasting blood glucose, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, TG triglycerides, HDL-C high-
density lipoprotein cholesterol
* Indicates significant difference between men and women, P \ 0.05
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It is generally accepted that obesity, as defined by BMI,
increases the risk of type-2 diabetes [2], hypertension [2],
cardiovascular disease [3], and all-cause mortality [4].
Unfortunately, the appropriate cutoff points to best identify
at-risk individuals are not consistent across different popu-
lations. Although a number of authors and groups have
proposed alternative BMI criteria specific to Asian popula-
tions [35, 36], there currently exists no consensus [37]. In
fact, the most recent attempt on behalf of the World Health
Organization (WHO) concluded that since the BMI cutoffs at
which significant cardiometabolic risk begins varies
between 26.0 and 31.0 kg/m2, depending on country, no
attempt was made to redefine cutoff points for Asian popu-
lations [37]. Unfortunately, in terms of tracking population
obesity level and accurately identifying individuals at car-
diometabolic risk, such matters are not trivial. For example,
the prevalence of obesity in Taiwan is 10.5% in men
and 13.2% in women when using the BMI cutoffs of
C27.0 kg/m2, but 2.4 and 5.6%, respectively, when applying
the BMI C30.0 kg/m2 cutoffs [26]. The results of our ROC
analysis suggest that the ideal BMI cutoffs for identifying
cardiometabolic risk in Taiwanese men and women are
24.5–25.7 kg/m2 and 22.6 and 24.0 kg/m2, respectively.
Nevertheless, the central deposition of excess weight has
been proven to be a stronger predictor of risk of morbidity
[6–10] and mortality [11] in comparison with overall
obesity. Although WC is often used as a marker of central
obesity, and its use has been adopted into clinical screening
guidelines [13], WC cutoff points cannot be used univer-
sally across gender or race [14]. Indeed, optimal WC cut-
offs for denoting cardiometabolic risk may not only differ
between Asians and Caucasians [14], but also between
Asians from different countries [15, 16]. It is suggested that
optimal WC cutoffs for abdominal obesity among men and
women in Japan are 85 and 90 cm [38], respectively, while
those in Korea are 90 and 85 cm [39]. By comparison, the
results of the current study illustrate that the optimal WC
cutoffs for predicting cardiometabolic risk among Tai-
wanese are between 83.7 and 89.4 cm in men and between
73.5 and 80.4 cm in women. In unison, these results
highlight the variability in WC thresholds between race,
gender, and even country of origin. Finally, the measure-
ment of WC also ignores the reported influence of height
on cardiometabolic risk [17, 40].
The WHtR is an alternative anthropometric index of
central obesity that circumvents the limitations of WC by
adjusting for variations in height and providing a universal
cutoff value equally appropriate for use among Asian and
Caucasian, as well as men and women [18, 19, 21–23, 41].
Specifically, Ashwell and Hsieh [18] have recently sug-
gested that a WHtR threshold of 0.5 is appropriate to
delineate patients with significant cardiometabolic risk
from those without, regardless of sex and race. Our results
in Taiwanese adults corroborate these suggestions, finding
that the optimal threshold for identifying cardiometabolic
risk was between 0.48 and 0.51 in the men and 0.47 and
0.50 in the women. Thus, a major advantage of WHtR over
WC appears to be simplicity. Such an advantage could
translate to enhanced delivery of public health messages
aimed at reducing obesity rates, as well as the clinical
screening of individuals at risk of cardiometabolic com-
plications. To that end, Ashwell and Hsieh [18] suggest the
following message: ‘‘Keep your waist circumference to less
than half your height.’’
Table 6 Demographic and cardiometabolic risk factors in normal waist circumference (men \ 90 cm, women \ 80 cm) adults by WHtR
Men (n = 15,261)
Waist-to-height ratio
Women (n = 12,208)
Waist-to-height ratio
\0.514 (n = 13,562) C0.514 (n = 1,699) P value \0.497 (n = 11,530) C0.497 (n = 678) P value
Age (years) 35.87 ± 8.42 43.02 ± 11.35 \0.001* 35.57 ± 8.79 44.33 ± 12.81 \0.001*
SBP (mm Hg) 123.59 ± 12.49 129.39 ± 14.03 \0.001* 112.32 ± 13.14 122.83 ± 18.76 \0.001*
DBP (mm Hg) 76.78 ± 9.09 80.89 ± 10.15 \0.001* 70.39 ± 8.93 74.93 ± 10.66 \0.001*
FBG (mg/dl) 89.68 ± 14.31 95.55 ± 21.88 \0.001* 87.47 ± 11.91 94.09 ± 21.37 \0.001*
TC (mg/dl) 179.92 ± 31.56 193.99 ± 35.16 \0.001* 175.83 ± 31.17 188.24 ± 35.63 \0.001*
TG (mg/dl) 111.60 ± 83.77 159.34 ± 132.43 \0.001* 73.78 ± 40.05 113.64 ± 88.51 \0.001*
HDL-C (mg/dl) 51.82 ± 11.28 47.80 ± 10.86 \0.001* 63.60 ± 12.94 57.09 ± 11.98 \0.001*
TC/HDL-C ratio 3.61 ± 0.95 4.22 ± 1.17 \0.001* 2.85 ± 0.67 3.41 ± 0.85 \0.001*
Uric acid 6.39 ± 1.19 6.71 ± 1.28 \0.001* 4.51 ± 0.91 5.06 ± 1.12 \0.001*
Values are means ± SD, and P values are from independent two sample t tests
FBG fasting blood glucose, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, TG triglycerides, HDL-C high-
density lipoprotein cholesterol
* Indicates significant difference between men and women, P \ 0.05
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Some authors suggest that WHtR may be the best simple
anthropometric index for predicting a wide range of car-
diometabolic risk factors associated with central obesity
[18, 21, 41]. The results of our ROC analyses illustrated
that in both sexes, the WHtR was superior to BMI and WC
as a predictor of diabetes mellitus, hypertension, high TC,
high TG, and low HDL-C. Additionally, in the women, the
WHtR was also the best predictor of MS. Nevertheless, the
results of logistic regression analysis, which investigated
the relationship between a 1 SD increase in any of the three
indices and the risk of MS, suggested that an increase in
BMI had a slightly greater impact on MS risk in compar-
ison with WHtR and WC. Thus, for optimal assessment of
a patient’s cardiometabolic risk, it may be ideal to use BMI
in concert with a measure of central adiposity such as WC
and WHtR, as has been previously suggested in clinical
guidelines [13]. In prior studies, WHtR has also been
shown to denote cardiometabolic risk among individuals
who are not obese according to other anthropometric
indices [23–25]. In agreement with these prior observa-
tions, the current study found that an elevated WHtR was
able to predict elevated cardiometabolic risk in both men
and women who had a normal BMI or WC level. Thus,
WHtR may also be able to identify cardiometabolic risk
among individuals deemed ‘healthy’ according to BMI and
WC.
A number of limitations are inherent to the current study
and warrant mention. First, since the study is cross-sec-
tional in nature, future longitudinal studies assessing the
prospective risk of cardiovascular disease and related
mortality according to each anthropometric index are
needed to fully elucidate the reported relationships.
Although diet and physical activity are known confounders
of the relationship between anthropometry and cardiomet-
abolic risk, due to a lack of relevant data, these variables
were not accounted for in the analysis. While we did not
quantify the extent of the intra- and inter-observer error in
the measurement of the various anthropometric outcomes,
we took a number of precautions to ensure quality control
in the collection of data (as described in the ‘‘Methods’’
sect.). Finally, we were also unable to examine the
potential mechanisms behind the relationship between
anthropometric markers and cardiometabolic risk factors.
Nevertheless, the notable strength of the current study
included data from over 36,000 men and women from both
southern and northern parts of Taiwan as well as rigorous
and comprehensive statistical analyses.
In conclusion, WHtR is a simple and effective index of
cardiometabolic risk among Taiwanese men and women,
which may be superior to BMI and WC. Indeed, a WHtR of
[0.5 was shown to clearly identify men and women at an
elevated risk of diabetes, hypertension, metabolic syn-
drome, and dyslipidemia. Our findings also highlight the
variability in optimal cutoff points for established anthro-
pometric indices of risk, such as BMI and WC, and
reconfirm the notion that these values are lower in Asian
versus Caucasian populations. Finally, our analyses
revealed that WHtR can identify adults at cardiometabolic
risk, even when such individuals are categorized as ‘heal-
thy’ or ‘normal’ according to BMI or WC.
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